ANEB icon

Anebulo Pharmaceuticals

12 hedge funds and large institutions have $17.1M invested in Anebulo Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
2L
1
22NW LP
Washington
$12.3M
LA
2
LVW Advisors
New York
$1.63M -$2.55K -1,050 -0.2%
NCM
3
Nantahala Capital Management
Connecticut
$1.24M
MP
4
Mangrove Partners
Connecticut
$968K
PCM
5
Praetorian Capital Management
Florida
$436K +$436K +180,005 New
IC
6
Ikarian Capital
Texas
$375K
HIG
7
Herr Investment Group
Texas
$71.8K +$71.8K +29,644 New
BFM
8
Boothbay Fund Management
New York
$42K
BlackRock
9
BlackRock
New York
$17.7K +$388 +160 +2%
TRCT
10
Tower Research Capital (TRC)
New York
$9K -$9.34K -3,733 -51%
UBS Group
11
UBS Group
Switzerland
$4.1K -$2.63K -1,085 -39%
Wells Fargo
12
Wells Fargo
California
$131 +$41 +17 +46%
Morgan Stanley
13
Morgan Stanley
New York
-$2K -600 Closed